Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypertension Stage 1”

Showing 20 of 0 results

Not applicableUnknownNCT06047678
What this trial is testing

Acute Effect of Individual Variants of Agonist-antagonist and Traditional Agonistic Resistance Training on Cardiovascular Parameters

Who this might be right for
Arterial StiffnessHypertensionCardiovascular Diseases
Charles University, Czech Republic 47
Early research (Phase 1)Study completedNCT05993806
What this trial is testing

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Who this might be right for
Essential Hypertension
Celltrion 50
Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Not applicableStudy completedNCT03479697
What this trial is testing

HIRREM for Stage 1 Primary Hypertension

Who this might be right for
HypertensionBlood PressureCardiovascular Diseases+2 more
Wake Forest University Health Sciences 5
Early research (Phase 1)UnknownNCT04185090
What this trial is testing

To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male Adults

Who this might be right for
HypertensionDyslipidemias
IlDong Pharmaceutical Co Ltd 30
Large-scale testing (Phase 3)UnknownNCT06141200
What this trial is testing

NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial

Who this might be right for
Essential Hypertension
Natural Wellness Egypt 286
Early research (Phase 1)Study completedNCT01289899
What this trial is testing

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 16
Testing effectiveness (Phase 2)Ended earlyNCT01725256
What this trial is testing

Determine the Safety and Efficacy of AIR001 in Subjects With Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 29
Early research (Phase 1)Study completedNCT03901781
What this trial is testing

Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

Who this might be right for
Ocular Hypertension
Noveome Biotherapeutics, formerly Stemnion 9
Testing effectiveness (Phase 2)Looking for participantsNCT07770685
What this trial is testing

A Study About the Safety of ASP2767 and Whether it Helps People With Glaucoma-Related Optic Nerve Damage

Who this might be right for
Glaucoma
Astellas Pharma Global Development, Inc. 156
Not applicableWithdrawnNCT07252037
What this trial is testing

Dietary Guidelines for Americans-Ultra Processed Study

Who this might be right for
Overweight , ObesityClass I Obesity
USDA Grand Forks Human Nutrition Research Center
Post-approval studies (Phase 4)Study completedNCT00168779
What this trial is testing

Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Comparing Telmisartan vs Valsartan. Taken Orally for Eight Weeks in Patients With Stage 1 and Stage 2 Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 1,185
Post-approval studies (Phase 4)Study completedNCT00403481
What this trial is testing

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

Who this might be right for
Hypertension
Daiichi Sankyo 192
Post-approval studies (Phase 4)UnknownNCT02894723
What this trial is testing

L-arginine Treatment in Mild Hypertension

Who this might be right for
Hypertension
Meir Medical Center 40
Testing effectiveness (Phase 2)Ended earlyNCT03924154
What this trial is testing

RVT-1201 in Patients With Pulmonary Arterial Hypertension (ELEVATE 1)

Who this might be right for
Pulmonary Arterial Hypertension
Altavant Sciences GmbH 3
Early research (Phase 1)UnknownNCT05077462
What this trial is testing

A Clinical Trial to Evaluate the Safety and Pharmacokinetics of AJU-C52H in Healthy Volunteers

Who this might be right for
Hypertension
AJU Pharm Co., Ltd. 60
Early research (Phase 1)Study completedNCT00435331
What this trial is testing

6R-BH4 Pulmonary Arterial Hypertension Study

Who this might be right for
Pulmonary Arterial Hypertension
Vanderbilt University 14
Early research (Phase 1)Study completedNCT00638742
What this trial is testing

A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost.

Who this might be right for
GlaucomaOcular Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 47
Early research (Phase 1)Study completedNCT00662610
What this trial is testing

Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood Pressure

Who this might be right for
OsteoarthritisHypertension
NicOx 120
Early research (Phase 1)Study completedNCT01389609
What this trial is testing

Bioequivalence Study of Doxazosin 4 Mg Orally-Disintegrating Tablet With Or Without Water To Doxazosin 4 Mg Japanese Marketed Immediate Release Tablet Under Fasted Condition

Who this might be right for
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 24
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation